Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-06-004630
Filing Date
2006-09-13
Accepted
2006-09-13 15:54:21
Documents
1
Period of Report
2006-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 3150
  Complete submission text file 0001005477-06-004630.txt   5151
Mailing Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078
Business Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078 44 1382 207506
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 150 JOHN F. KENNEDY PARKWAY, SUITE 100 SHORT HILLS NJ 07078
Business Address 973-847-5955
Rombotis Spiro (Reporting) CIK: 0001357396 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 061088605